MATERIAL SAFETY DATA SHEET
Hydromorphone Hydrochloride
PADDOCK LABORATORIES, INC. EMERGENCY ASSISTANCE:
3940 QUEBEC AVENUE NORTH CHEMTREC 800-424-9300
MINNEAPOLIS, MINNESOTA 55427 202-483-7616
PHONE: (763)-546 -4676 PADDOCK TECH. ASST. 800-328-5113
Date prepared: February 15, 1996 By: Matthew Greuel
SECTION 1 - PRODUCT IDENTIFICATION AND HAZARDOUS COMPONENTS
PRODUCT NAME: Hydromorphone Hydrochloride
SYNONYMS: Dihydromorphinone Hydrochloride
MOLECULAR FORMULA: C17 H19NO3 HCl MOLECULAR WEIGHT: 322.5
CHEMICAL NAME: Morphinan-6-one,4,5-epoxy-3-hydroxy-17- methyl-,hydrochloride, (5 alpha)
CHEMICAL FAMILY: Morphinan derivative
INGREDIENT (CAS NUMBER) % OSHA PEL ACGIH TLV
Hydromorphone Hydrochloride (71-68-1) 100 not established not established
SECTION 2 - PHYSICAL AND CHEMICAL CHARACTERISTICS
BOILING POINT: N/A VAPOR PRESSURE: N/A
MELTING POINT: 305-315o C. w/Decomposition VAPOR DENSITY: N/A
SPECIFIC GRAVITY: N/A EVAPORATION RATE: N/A
(WATER = 1) (BUTYL ACETATE = 1)
WATER SOLUBILITY: Freely soluble WATER REACTIVE: No
APPEARANCE AND ODOR: Fine, white or practically white, odorless, crystalline powder.
SECTION 3 - FIRE AND EXPLOSION DATA
FLASH POINT (METHOD): N/A NFPA RATING: N/A
AUTOIGNITION TEMPERATURE: N/A
FLAMMABLE LIMITS: LOWER: N/A UPPER: N/A
EXTINGUISHING MEDIA: Water spray, carbon dioxide, dry chemical, or foam as appropriate for
surrounding fire conditions and materials. Class BC, ABC fire extinguishers
SPECIAL FIRE FIGHTING PROCEDURES: As with all fires, evacuate personnel to safe area. Firefighters
should use self- contained breathing equipment and protective clothing.
UNUSUAL FIRE AND EXPLOSION HAZARDS: This material is assumed to be combustible. As with all
dry powders it is advisable to ground mechanical equipment in contact with dry material to dissipate the
potential buildup of static electricity. When heated to decomposition material emits toxic fumes of NOx and
HCl. Emits toxic fumes under fire conditions.
SECTION 4 - REACTIVITY HAZARD DATA
STABILITY: Stable ( X ) Unstable ( )
INCOMPATIBILITY (MATERIALS TO AVOID): Oxidizing agents, and heavy metal salts
HAZARDOUS DECOMPOSITION PRODUCTS: Produces toxic fumes ( NOx , and HCl ) when heated to
decomposition.
HAZARDOUS POLYMERIZATION: May Occur ( ) Will Not Occur ( X )
SECTION 5 - HEALTH HAZARD DATA
TOXICITY: LD50 : Subcutaneous (rat) 51mg/kg
Subcutaneous (mouse) 120 mg/kg
Intravenous (mouse) 55 mg/kg
LDLo: Intravenous (cat) 3 mg/kg
Intravenous (rabbit) 2500 micrograms/kg
Reproductive Effects Data [RTECS]
The usual adult oral dose of hydromorphone hydrochloride is 2 mg every three to six hours as needed.
Adverse effects include dizziness, sedation, nausea, vomiting, constipation, abdominal pain, skin rashes,
lightheadedness, headache, weakness, euphoria, dysphoria, hallucinations, visual disturbances, liver
dysfunction and palpitations. Central nervous system depression, respiratory depression, pinpoint pupils,
coma, body temperature and blood pressure may fall. Possible allergic reaction to dust if inhaled,
ingested or in contact with skin.
CARCINOGEN LISTED BY: NTP Yes ( ) No ( X )
IARC Yes ( ) No ( X )
OSHA Yes ( ) No ( X )
Other Yes ( ) No (X )
ACGIH Other exposure
TLV: n/a Limits Used: n/a
SIGNS AND SYMPTOMS OF OVEREXPOSURE:
INHALATION: Respiratory tract irritation possible. Remove to fresh air.
EYE CONTACT: Possible Irritation, Flush with copious quantities of water, may cause narcotic effect
exhibited by pupil contraction
SKIN CONTACT: Possible Irritation, Flush with copious quantities of water.
INGESTION: Narcotic. In addition to analgesic action, may cause gastric disturbance evidenced by
nausea, vomiting, and constipation. Ingestion of large amounts may cause central nervous system
depression, respiratory or cardiac collapse, coma and death.
CHRONIC EFFECTS OF OVEREXPOSURE: May cause addiction. Possible hypersensitization to this
material.
MEDICAL CONDITIONS AGGRAVATED BY OVEREXPOSURE: Sensitization may occur evidenced by
skin rashes, cough, stuffy nose, asthma and other allergic complaints.
OTHER PRECAUTIONS TO CONSIDER: Persons developing hypersensitivity (anaphylactic) reactions must
receive immediate medical attention. Material may be irritating to mucous membranes and respiratory
tract. Risk-benefit must be considered because opioid analgesics cross the placenta. Regular use during
pregnancy may cause physical dependency in the fetus, leading to withdrawal symptoms (convulsions,
irritability, excessive crying, tremors, hyperactive reflexes, fever, vomiting, diarrhea, sneezing and
yawning) in the neonate. Although teratogenic effects in humans have not been documented, controlled
studies have not been done. Studies in animals have shown hydromorphone to be teratogenic in very
high doses (FDA pregnancy Category C) [USP DI 9th ed. 1989]. As a general rule, when handling
Hydromorphone Hydrochloride, avoid all contact and inhalation of dust, fumes, mists, and/or vapors
associated with the material. Keep container tightly closed and use with adequate ventilation; wash
thoroughly after handling. Individuals working with chemicals should consider all chemicals to be
potentially hazardous even if their individual hazards may be uncharacterized or unknown.
EMERGENCY FIRST AID PROCEDURES:
INHALATION: Seek immediate medical attention.
EYE CONTACT: Flush with copious amounts of water. Obtain medical attention.
SKIN CONTACT: Flush with copious amounts of water. Obtain medical attention.
INGESTION: Seek immediate medical attention.
SECTION 6 - CONTROL AND PROTECTIVE MEASURES
RESPIRATORY PROTECTION: NIOSH/MSHA approved respirator.
PROTECTIVE GLOVES: Rubber or Latex.
EYE PROTECTION: Safety goggles. Avoid wearing contact lenses when working with this or any chemical
due to the possibility of increased severity of eye damage.
VENTILATION: General or local exhaust recommended.
OTHER PROTECTIVE EQUIPMENT: Appropriate laboratory apparel. Protect exposed skin.
HYGIENIC WORK PRACTICES: Do not eat, drink or smoke near this material. Wash thoroughly after
handling and wash contaminated clothing before reuse.
SECTION 7 - HANDLING AND STORAGE PRECAUTIONS
STORAGE PRECAUTIONS: CONTROLLED SUBSTANCE (Schedule II). Storage location must comply
with all Drug Enforcement Administration regulations. Store in a tight container in a cool, dry, well ventilated
location.
SECTION 8 - SPILL AND DISPOSAL PROCEDURES
WASTE DISPOSAL METHOD: Dispose of in accordance with all applicable local, state, federal, and
environmental regulations.
SECTION 9 - DISCLAIMER
__________________________________________________________________________________________
DEFINITIONS OF ABBREVIATIONS USED:
ACGIH: American Conference of Governmental Industrial Hygienists
CAS: Chemical Abstract Service
IARC: Internal Agency for Research on Cancer
IDLH: Immediately Dangerous to Life or Health level
LC50 : Median Lethal Concentration
LD50 : Median Lethal Dose
MSHA: Mine Safety and Health Administration
N/A: Not available
NIOSH: National Institute for Occupational Safety and Health
NTP: National Toxicology Program
OSHA: Occupational Safety and Health Administration
PEL: Permissible Exposure Limit
STEL: Short Term Exposure Limit
TLV: Threshold Limit Value
TWA: Time Weighted Average
|